Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer drugs
Biotech
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Merck KGaA has become the latest biopharma to swell its oncology pipeline with further antibody-drug conjugate potential this week.
James Waldron
Apr 4, 2024 8:25am
Prelude thinks SMARCA with AbCellera deal, culls 2 candidates
Nov 2, 2023 8:06am
Ariceum bolsters radiopharma efforts with Theragnostics buy
Jun 1, 2023 10:35am
2022's 10 top clinical trial flops
Feb 21, 2023 3:00am
Follow-up trials should be underway for accelerated nods: Pazdur
Nov 17, 2022 3:36pm
Medable tech to improve access, diversity across oncology trials
Oct 27, 2022 5:30am